Pub Date : 2017-01-01Epub Date: 2017-07-27DOI: 10.1159/000475089
Henryk A Domansk, Charles S Walther
{"title":"Sampling and Preparation Techniques.","authors":"Henryk A Domansk, Charles S Walther","doi":"10.1159/000475089","DOIUrl":"https://doi.org/10.1159/000475089","url":null,"abstract":"","PeriodicalId":18805,"journal":{"name":"Monographs in clinical cytology","volume":"22 ","pages":"13-14"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000475089","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35204032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-01-01Epub Date: 2017-07-27DOI: 10.1159/000475099
Henryk A Domansk, Charles S Walther
{"title":"Vascular Tumors.","authors":"Henryk A Domansk, Charles S Walther","doi":"10.1159/000475099","DOIUrl":"https://doi.org/10.1159/000475099","url":null,"abstract":"","PeriodicalId":18805,"journal":{"name":"Monographs in clinical cytology","volume":"22 ","pages":"80-88"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000475099","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35203415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-01-01Epub Date: 2017-07-27DOI: 10.1159/000475101
Henryk A Domansk, Charles S Walther
{"title":"Nerve Sheath Tumors.","authors":"Henryk A Domansk, Charles S Walther","doi":"10.1159/000475101","DOIUrl":"https://doi.org/10.1159/000475101","url":null,"abstract":"","PeriodicalId":18805,"journal":{"name":"Monographs in clinical cytology","volume":"22 ","pages":"92-102"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000475101","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35203417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-01-01Epub Date: 2011-10-18DOI: 10.1159/000331027
Deborah J Chute, Charles V Biscotti, Arun D Singh
Primary uveal lymphoma is rare and, unlike the vitreoretinal lymphomas, is typically indolent in nature [1– 3]. In the past these tumors were termed ‘reactive lymphoid hyperplasia’ or ‘uveal pseudotumor’ because of their lowgrade appearance [4– 6]. However, convincing evidence with modern techniques has demonstrated that the majority of these lesions are lowgrade Bcell lymphomas, most commonly extranodal marginal zone Bcell lymphomas [1, 5, 7] according to the current WHO classification (table 1) [8]. Primary highgrade lymphomas involving the uvea are extremely rare [26]. Uveal lymphoma may be considered primary if the uvea is the only or the initial site and secondary if there is secondary involvement of the uvea by systemic nonHodgkin lymphoma [13, 27– 34]. Hence, a careful clinical evaluation for involvement of other sites is required at the time of initial diagnosis and subsequent followup.
{"title":"Uveal lymphoma.","authors":"Deborah J Chute, Charles V Biscotti, Arun D Singh","doi":"10.1159/000331027","DOIUrl":"https://doi.org/10.1159/000331027","url":null,"abstract":"Primary uveal lymphoma is rare and, unlike the vitreoretinal lymphomas, is typically indolent in nature [1– 3]. In the past these tumors were termed ‘reactive lymphoid hyperplasia’ or ‘uveal pseudotumor’ because of their lowgrade appearance [4– 6]. However, convincing evidence with modern techniques has demonstrated that the majority of these lesions are lowgrade Bcell lymphomas, most commonly extranodal marginal zone Bcell lymphomas [1, 5, 7] according to the current WHO classification (table 1) [8]. Primary highgrade lymphomas involving the uvea are extremely rare [26]. Uveal lymphoma may be considered primary if the uvea is the only or the initial site and secondary if there is secondary involvement of the uvea by systemic nonHodgkin lymphoma [13, 27– 34]. Hence, a careful clinical evaluation for involvement of other sites is required at the time of initial diagnosis and subsequent followup.","PeriodicalId":18805,"journal":{"name":"Monographs in clinical cytology","volume":"21 ","pages":"31-43"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000331027","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30229566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-01-01Epub Date: 2011-10-18DOI: 10.1159/000331038
Mohammad Javed Ali, Santosh G Honavar, Geeta K Vemuganti, Arun D Singh
Although there is enough literature on fine needle aspiration biopsy (FNAB) of uveal tumors, the same is not true for retinal tumors, possibly because of the paucity of clear indications and guidelines. Certain general indications and contraindications for FNAB have been formulated based on a review of the literature of published studies [1, 2]. We have listed those that are relevant to retinal tumors (table 1). It has to be emphasized that FNAB is recommended only in highly selected cases where there is a true diagnostic dilemma after all possible clinical investigations including an opinion by an expert ocular oncologist have been obtained. In this chapter, we review such specific indications that may warrant FNAB of frequently encountered retinal tumors.
{"title":"Fine needle aspiration biopsy of retinal tumors.","authors":"Mohammad Javed Ali, Santosh G Honavar, Geeta K Vemuganti, Arun D Singh","doi":"10.1159/000331038","DOIUrl":"https://doi.org/10.1159/000331038","url":null,"abstract":"Although there is enough literature on fine needle aspiration biopsy (FNAB) of uveal tumors, the same is not true for retinal tumors, possibly because of the paucity of clear indications and guidelines. Certain general indications and contraindications for FNAB have been formulated based on a review of the literature of published studies [1, 2]. We have listed those that are relevant to retinal tumors (table 1). It has to be emphasized that FNAB is recommended only in highly selected cases where there is a true diagnostic dilemma after all possible clinical investigations including an opinion by an expert ocular oncologist have been obtained. In this chapter, we review such specific indications that may warrant FNAB of frequently encountered retinal tumors.","PeriodicalId":18805,"journal":{"name":"Monographs in clinical cytology","volume":"21 ","pages":"72-81"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000331038","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30229570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-01-01Epub Date: 2011-10-18DOI: 10.1159/000331042
Arun D Singh, Braeden Dolan, Charles V Biscotti
{"title":"Future of ophthalmic fine needle aspiration biopsy.","authors":"Arun D Singh, Braeden Dolan, Charles V Biscotti","doi":"10.1159/000331042","DOIUrl":"https://doi.org/10.1159/000331042","url":null,"abstract":"","PeriodicalId":18805,"journal":{"name":"Monographs in clinical cytology","volume":"21 ","pages":"90-6"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000331042","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30229572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-01-01Epub Date: 2011-10-18DOI: 10.1159/000331019
Arun D Singh, David E Pelayes, Jennifer A Brainard, Charles V Biscotti
{"title":"History, indications, techniques and limitations.","authors":"Arun D Singh, David E Pelayes, Jennifer A Brainard, Charles V Biscotti","doi":"10.1159/000331019","DOIUrl":"https://doi.org/10.1159/000331019","url":null,"abstract":"","PeriodicalId":18805,"journal":{"name":"Monographs in clinical cytology","volume":"21 ","pages":"1-9"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000331019","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30229563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-01-01Epub Date: 2011-10-18DOI: 10.1159/000331039
Stefan Seregard, Edneia Tani
{"title":"Fine needle aspiration cytology in orbital tumors.","authors":"Stefan Seregard, Edneia Tani","doi":"10.1159/000331039","DOIUrl":"https://doi.org/10.1159/000331039","url":null,"abstract":"","PeriodicalId":18805,"journal":{"name":"Monographs in clinical cytology","volume":"21 ","pages":"82-9"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000331039","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30229571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-01-01Epub Date: 2011-10-18DOI: 10.1159/000331035
Mary E Turell, Raymond R Tubbs, Charles V Biscotti, Arun D Singh
{"title":"Uveal melanoma: prognostication.","authors":"Mary E Turell, Raymond R Tubbs, Charles V Biscotti, Arun D Singh","doi":"10.1159/000331035","DOIUrl":"https://doi.org/10.1159/000331035","url":null,"abstract":"","PeriodicalId":18805,"journal":{"name":"Monographs in clinical cytology","volume":"21 ","pages":"55-60"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000331035","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30229568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-01-01Epub Date: 2011-10-18DOI: 10.1159/000330816
Charles V Biscotti, Arun D Singh
Any discussion of ophthalmic oncology must emphasize metastases to the uvea. Consider that an estimated 8– 10% of patients with metastatic malignancy have uveal involvement [1]. Not surprisingly then, metastases are the most common uveal malignancy. The uveal tract’s rich vascularity partly explains this predilection for metastases. Further, the uveal microenvironment seems favorable to metastases since the uvea has the highest percentage of metastatic involvement in relation to blood flow of any tissue in the body [1, 2]. Metastases usually involve the choroid (88% of cases) and rarely involve the iris (9% of cases) or ciliary body (2% of cases) [3]. Multifocality and or bilaterality can help clinically differentiate metastases from primary tumors, especially melanoma. Unfortunately, metastases are often solitary and unilateral [3, 4]. In one large series, metastases were bilateral in only approximately one quarter of patients, and the metastases were solitary in 71% of the involved eyes [3]. Two thirds of patients with uveal metastases have a history of a primary malignancy [3]. Cytologists should exploit this fact when interpreting uveal fine needle aspiration biopsy (FNAB) samples.
{"title":"Uveal metastases.","authors":"Charles V Biscotti, Arun D Singh","doi":"10.1159/000330816","DOIUrl":"https://doi.org/10.1159/000330816","url":null,"abstract":"Any discussion of ophthalmic oncology must emphasize metastases to the uvea. Consider that an estimated 8– 10% of patients with metastatic malignancy have uveal involvement [1]. Not surprisingly then, metastases are the most common uveal malignancy. The uveal tract’s rich vascularity partly explains this predilection for metastases. Further, the uveal microenvironment seems favorable to metastases since the uvea has the highest percentage of metastatic involvement in relation to blood flow of any tissue in the body [1, 2]. Metastases usually involve the choroid (88% of cases) and rarely involve the iris (9% of cases) or ciliary body (2% of cases) [3]. Multifocality and or bilaterality can help clinically differentiate metastases from primary tumors, especially melanoma. Unfortunately, metastases are often solitary and unilateral [3, 4]. In one large series, metastases were bilateral in only approximately one quarter of patients, and the metastases were solitary in 71% of the involved eyes [3]. Two thirds of patients with uveal metastases have a history of a primary malignancy [3]. Cytologists should exploit this fact when interpreting uveal fine needle aspiration biopsy (FNAB) samples.","PeriodicalId":18805,"journal":{"name":"Monographs in clinical cytology","volume":"21 ","pages":"17-30"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000330816","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30229565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：